"Apolipoprotein B-48" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 241-kDa protein synthesized only in the INTESTINES. It serves as a structural protein of CHYLOMICRONS. Its exclusive association with chylomicron particles provides an indicator of intestinally derived lipoproteins in circulation. Apo B-48 is a shortened form of apo B-100 and lacks the LDL-receptor region.
Descriptor ID |
D053283
|
MeSH Number(s) |
D10.532.091.300.240 D12.776.070.400.300.240 D12.776.521.120.300.240
|
Concept/Terms |
Apolipoprotein B-48- Apolipoprotein B-48
- Apolipoprotein B 48
- Apo B-48
- Apo B 48
- ApoB-48
- ApoB 48
- ApoB48
- Apolipoprotein B48
- Apoprotein B-48
- Apoprotein B 48
- Chylomicron Apo B
- Chylomicron Apolipoprotein B
- Apo B, Chylomicron
- Apolipoprotein B, Chylomicron
|
Below are MeSH descriptors whose meaning is more general than "Apolipoprotein B-48".
Below are MeSH descriptors whose meaning is more specific than "Apolipoprotein B-48".
This graph shows the total number of publications written about "Apolipoprotein B-48" by people in this website by year, and whether "Apolipoprotein B-48" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 1 | 1 |
2008 | 1 | 1 | 2 |
2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Apolipoprotein B-48" by people in Profiles.
-
Wu J, Xiao Y, Liu J, Yang H, Dong X, Hu S, Jin S, Wu D. Potential role of ATM in hepatocyte endocytosis of ApoE-deficient, ApoB48-containing lipoprotein in ApoE-deficient mice. Int J Mol Med. 2014 Feb; 33(2):462-8.
-
Wu D, Yang H, Zhao Y, Sharan C, Goodwin JS, Zhou L, Guo Y, Guo Z. 2-Aminopurine inhibits lipid accumulation induced by apolipoprotein E-deficient lipoprotein in macrophages: potential role of eukaryotic initiation factor-2alpha phosphorylation in foam cell formation. J Pharmacol Exp Ther. 2008 Aug; 326(2):395-405.
-
Nerurkar PV, Lee YK, Motosue M, Adeli K, Nerurkar VR. Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions. Br J Nutr. 2008 Oct; 100(4):751-9.
-
V?lez-Carrasco W, Lichtenstein AH, Barrett PH, Sun Z, Dolnikowski GG, Welty FK, Schaefer EJ. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins. J Lipid Res. 1999 Sep; 40(9):1695-700.